U.S. futures for the S&P 500 were up 1.2% and futures for the Dow Jones Industrial Average rose 0.5%. Changes in futures don't necessarily predict movements.
By Anthony O. Goriainoff and Ian Walker Indivior shares rose as much as 22% after the company said that it was sounding out investors over a possible move to.
By Najat Kantouar Indivior said it has reached an agreement with Actavis Laboratories UT to resolve patent disputes regarding Actavis's Abbreviated New Drug.
By Christian Moess Laursen Indivior said the U.K. high court has removed securities claims against the company and Reckitt Benckiser in separate legal cases.
By Joe Hoppe Indivior said it has extended its relationship agreement with shareholder Scopia Capital Management, extending the board tenure of director.